PFM Health Sciences’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-52,120	Closed	-$1.77M	–	80
2024 Q3	$1.77M	Hold	52,120	–	–	0.1%	69
2024 Q2	$1.93M	Buy	52,120 +17,120	+49%	+$634K	0.1%	66
2024 Q1	$1.47M	Hold	35,000	–	–	0.07%	80
2023 Q4	$1.39M	Buy	+35,000	New	+$1.39M	0.08%	63